401k Plan data: KEDRION BIOPHARMA INC. 401(K) PLAN plan

KEDRION BIOPHARMA INC. 401(K) PLAN 401k Plan overview

Plan Name	KEDRION BIOPHARMA INC. 401(K) PLAN
Plan identification number	001

KEDRION BIOPHARMA INC. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

KEDRION BIOPHARMA INC. has sponsored the creation of one or more 401k plans.

Company Name: KEDRION BIOPHARMA INC.

Employer identification number (EIN): 383841851

NAIC Classification: 621900

Form 5500 Filing Information

Submission information for form 5500 for 401k plan KEDRION BIOPHARMA INC. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01 ELIZABETH FAIRBROTHER 2023-11-27 AKOS TOTH 2023-11-28
001 2021-01-01 ELIZABETH FAIRBROTHER 2022-09-08 HELEN NASSER 2022-09-06
001 2020-01-01 ELIZABETH FAIRBROTHER 2021-10-06 PEER BAGGE HANSEN 2021-10-07
001 2019-01-01 ELIZABETH FAIRBROTHER 2020-10-12 PEER BAGGE HANSEN 2020-10-12
001 2018-01-01 ELIZABETH FAIRBROTHER 2019-10-11 PEER HANSEN 2019-10-15
001 2018-01-01 ELIZABETH FAIRBROTHER 2019-10-11 PEER HANSEN 2019-10-15

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01	ELIZABETH FAIRBROTHER	2023-11-27	AKOS TOTH	2023-11-28
001	2021-01-01	ELIZABETH FAIRBROTHER	2022-09-08	HELEN NASSER	2022-09-06
001	2020-01-01	ELIZABETH FAIRBROTHER	2021-10-06	PEER BAGGE HANSEN	2021-10-07
001	2019-01-01	ELIZABETH FAIRBROTHER	2020-10-12	PEER BAGGE HANSEN	2020-10-12
001	2018-01-01	ELIZABETH FAIRBROTHER	2019-10-11	PEER HANSEN	2019-10-15
001	2018-01-01	ELIZABETH FAIRBROTHER	2019-10-11	PEER HANSEN	2019-10-15

Plan Statistics for KEDRION BIOPHARMA INC. 401(K) PLAN

401k plan membership statisitcs for KEDRION BIOPHARMA INC. 401(K) PLAN

Measure Date Value
2022: KEDRION BIOPHARMA INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 1,252
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 1,151
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 158
Total of all active and inactive participants 2022-01-01 1,309
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 1,309
Number of participants with account balances 2022-01-01 550
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: KEDRION BIOPHARMA INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 1,184
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 962
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 196
Total of all active and inactive participants 2021-01-01 1,158
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 1,158
Number of participants with account balances 2021-01-01 585
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: KEDRION BIOPHARMA INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 1,173
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 1,008
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 132
Total of all active and inactive participants 2020-01-01 1,140
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 1,140
Number of participants with account balances 2020-01-01 525
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: KEDRION BIOPHARMA INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 1,010
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 971
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 144
Total of all active and inactive participants 2019-01-01 1,115
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 1,115
Number of participants with account balances 2019-01-01 473
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: KEDRION BIOPHARMA INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 865
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 819
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 157
Total of all active and inactive participants 2018-01-01 976
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 976
Number of participants with account balances 2018-01-01 472
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0

Measure	Date	Value
2022: KEDRION BIOPHARMA INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	1,252
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	1,151
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	158
Total of all active and inactive participants	2022-01-01	1,309
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	1,309
Number of participants with account balances	2022-01-01	550
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: KEDRION BIOPHARMA INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	1,184
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	962
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	196
Total of all active and inactive participants	2021-01-01	1,158
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	1,158
Number of participants with account balances	2021-01-01	585
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: KEDRION BIOPHARMA INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	1,173
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	1,008
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	132
Total of all active and inactive participants	2020-01-01	1,140
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	1,140
Number of participants with account balances	2020-01-01	525
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: KEDRION BIOPHARMA INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	1,010
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	971
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	144
Total of all active and inactive participants	2019-01-01	1,115
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	1,115
Number of participants with account balances	2019-01-01	473
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: KEDRION BIOPHARMA INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	865
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	819
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	157
Total of all active and inactive participants	2018-01-01	976
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	976
Number of participants with account balances	2018-01-01	472
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0

Financial Data on KEDRION BIOPHARMA INC. 401(K) PLAN

Measure	Date	Value
2022 : KEDRION BIOPHARMA INC. 401(K) PLAN 2022 401k financial data
Total income from all sources (including contributions)	2022-12-31	$1,016,929
Total of all expenses incurred	2022-12-31	$3,000,064
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$2,803,871
Expenses. Certain deemed distributions of participant loans	2022-12-31	$139,811
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$4,732,646
Value of total assets at end of year	2022-12-31	$26,747,301
Value of total assets at beginning of year	2022-12-31	$28,730,436
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$56,382
Total interest from all sources	2022-12-31	$49,341
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$2,622,284
Participant contributions at end of year	2022-12-31	$816,714
Participant contributions at beginning of year	2022-12-31	$710,189
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$788,249
Other income not declared elsewhere	2022-12-31	$-247
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-1,983,135
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$26,747,301
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$28,730,436
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in pooled separate accounts at end of year	2022-12-31	$24,127,478
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$26,254,770
Interest on participant loans	2022-12-31	$33,815
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2022-12-31	$15,526
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$1,734,369
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$1,676,844
Net investment gain/loss from pooled separate accounts	2022-12-31	$-3,764,811
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$1,322,113
Employer contributions (assets) at end of year	2022-12-31	$68,740
Employer contributions (assets) at beginning of year	2022-12-31	$88,633
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$2,803,871
Contract administrator fees	2022-12-31	$56,382
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	APRIO LLP
Accountancy firm EIN	2022-12-31	571157523
2021 : KEDRION BIOPHARMA INC. 401(K) PLAN 2021 401k financial data
Total income from all sources (including contributions)	2021-12-31	$7,770,114
Total of all expenses incurred	2021-12-31	$4,173,946
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$3,914,642
Expenses. Certain deemed distributions of participant loans	2021-12-31	$62,539
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$4,015,650
Value of total assets at end of year	2021-12-31	$28,730,436
Value of total assets at beginning of year	2021-12-31	$25,134,268
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$196,765
Total interest from all sources	2021-12-31	$52,025
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$2,643,295
Participant contributions at end of year	2021-12-31	$710,189
Participant contributions at beginning of year	2021-12-31	$760,814
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$61,478
Other income not declared elsewhere	2021-12-31	$132,863
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$3,596,168
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$28,730,436
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$25,134,268
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in pooled separate accounts at end of year	2021-12-31	$26,254,770
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$22,047,755
Interest on participant loans	2021-12-31	$33,562
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$2,572
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$2,572
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2021-12-31	$18,463
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$1,676,844
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$2,222,955
Net investment gain/loss from pooled separate accounts	2021-12-31	$3,569,576
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$1,310,877
Employer contributions (assets) at end of year	2021-12-31	$88,633
Employer contributions (assets) at beginning of year	2021-12-31	$100,172
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$3,914,642
Contract administrator fees	2021-12-31	$196,765
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	APRIO LLP
Accountancy firm EIN	2021-12-31	571157523
2020 : KEDRION BIOPHARMA INC. 401(K) PLAN 2020 401k financial data
Total income from all sources (including contributions)	2020-12-31	$7,012,492
Total of all expenses incurred	2020-12-31	$4,309,228
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$4,132,791
Expenses. Certain deemed distributions of participant loans	2020-12-31	$136,278
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$4,543,299
Value of total assets at end of year	2020-12-31	$25,134,268
Value of total assets at beginning of year	2020-12-31	$22,431,004
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$40,159
Total interest from all sources	2020-12-31	$61,779
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$2,527,374
Participant contributions at end of year	2020-12-31	$760,814
Participant contributions at beginning of year	2020-12-31	$832,104
Participant contributions at beginning of year	2020-12-31	$1,142
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$741,870
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$2,703,264
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$25,134,268
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$22,431,004
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in pooled separate accounts at end of year	2020-12-31	$22,047,755
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$20,389,584
Interest on participant loans	2020-12-31	$45,568
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$2,572
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$500
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$500
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$16,211
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$2,222,955
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$1,119,796
Net investment gain/loss from pooled separate accounts	2020-12-31	$2,407,414
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$1,274,055
Employer contributions (assets) at end of year	2020-12-31	$100,172
Employer contributions (assets) at beginning of year	2020-12-31	$87,878
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$4,132,791
Contract administrator fees	2020-12-31	$40,159
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	LB GOODMAN & CO
Accountancy firm EIN	2020-12-31	222562877
2019 : KEDRION BIOPHARMA INC. 401(K) PLAN 2019 401k financial data
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$900
Total income from all sources (including contributions)	2019-12-31	$7,513,740
Total of all expenses incurred	2019-12-31	$4,023,224
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$3,819,015
Expenses. Certain deemed distributions of participant loans	2019-12-31	$128,380
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$3,773,609
Value of total assets at end of year	2019-12-31	$22,431,004
Value of total assets at beginning of year	2019-12-31	$18,941,388
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$75,829
Total interest from all sources	2019-12-31	$52,316
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$2,266,109
Participant contributions at end of year	2019-12-31	$832,104
Participant contributions at beginning of year	2019-12-31	$559,159
Participant contributions at end of year	2019-12-31	$1,142
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$379,244
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2019-12-31	$900
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$3,490,516
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$22,431,004
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$18,940,488
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in pooled separate accounts at end of year	2019-12-31	$20,389,584
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$16,931,428
Interest on participant loans	2019-12-31	$36,422
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$500
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$15,894
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$1,119,796
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$1,363,918
Net investment gain/loss from pooled separate accounts	2019-12-31	$3,687,815
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$1,128,256
Employer contributions (assets) at end of year	2019-12-31	$87,878
Employer contributions (assets) at beginning of year	2019-12-31	$86,883
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$3,819,015
Contract administrator fees	2019-12-31	$75,829
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	LB GOODMAN & CO
Accountancy firm EIN	2019-12-31	222562877
2018 : KEDRION BIOPHARMA INC. 401(K) PLAN 2018 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$900
Total income from all sources (including contributions)	2018-12-31	$2,895,215
Total of all expenses incurred	2018-12-31	$3,713,506
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$3,573,915
Expenses. Certain deemed distributions of participant loans	2018-12-31	$101,846
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$4,177,047
Value of total assets at end of year	2018-12-31	$18,941,388
Value of total assets at beginning of year	2018-12-31	$19,758,779
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$37,745
Total interest from all sources	2018-12-31	$42,080
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$2,442,204
Participant contributions at end of year	2018-12-31	$559,159
Participant contributions at beginning of year	2018-12-31	$473,110
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$566,406
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2018-12-31	$860
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2018-12-31	$900
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-818,291
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$18,940,488
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$19,758,779
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in pooled separate accounts at end of year	2018-12-31	$16,931,428
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$18,066,865
Interest on participant loans	2018-12-31	$27,143
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$14,937
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$1,363,918
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$1,111,534
Net investment gain/loss from pooled separate accounts	2018-12-31	$-1,323,912
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$1,168,437
Employer contributions (assets) at end of year	2018-12-31	$86,883
Employer contributions (assets) at beginning of year	2018-12-31	$106,410
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$3,573,915
Contract administrator fees	2018-12-31	$37,745
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	LB GOODMAN & CO
Accountancy firm EIN	2018-12-31	222562877

Form 5500 Responses for KEDRION BIOPHARMA INC. 401(K) PLAN

2022: KEDRION BIOPHARMA INC. 401(K) PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	Yes
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: KEDRION BIOPHARMA INC. 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: KEDRION BIOPHARMA INC. 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: KEDRION BIOPHARMA INC. 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: KEDRION BIOPHARMA INC. 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	Yes
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

940797-01

Policy instance

Insurance contract or identification number	940797-01
Number of Individuals Covered	550
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

940797-01

Policy instance

Insurance contract or identification number	940797-01
Number of Individuals Covered	562
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

940797-01

Policy instance

Insurance contract or identification number	940797-01
Number of Individuals Covered	525
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

940797-01

Policy instance

Insurance contract or identification number	940797-01
Number of Individuals Covered	473
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

940797-01

Policy instance

Insurance contract or identification number	940797-01
Number of Individuals Covered	472
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes

Potentially related plans

KEDRION BIOPHARMA INC. EMPLOYEE BENEFITS PLAN [EIN = 981089930]

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	KEDRION BIOPHARMA INC.
Employer identification number (EIN):	383841851
NAIC Classification:	621900